Benign prostatic hyperplasia

3 trials MedDRA PT
3 Registered trials
0 Recruiting
3 Unique sponsors
3 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
G Urology/Gynaecology (ATC G) 2
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Triptan 1 substance
Phase III: 1 Phase II: 1 Phase I (Other): 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Azienda Ospedaliero Universitaria Careggi Academic
    SERENOA REPENS (BARTRAM) SMALL.
    2025-525123-27-00 1 country n=410
    Pending

Phase II

1 trial
  • CCAB Centro Clinico Academico Braga Associacao Academic
    OXITRIPTAN; TAMSULOSIN HYDROCHLORIDE
    2024-519076-75-00 1 country 2024 n=70
    Halted

Phase I (Other)

1 trial
  • Adamed Pharma S.A. Commercial
    IMP not specified
    2024-510774-24-00 1 country 2024 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Adamed Pharma S.A. Commercial 1 Phase I (Other) 0
CCAB Centro Clinico Academico Braga Associacao Academic 1 Phase II 0
Azienda Ospedaliero Universitaria Careggi Academic 1 Phase III 0
New trials by year
2024
2
← All indication landscapes